Literature DB >> 27216613

Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices.

Federico Lavorini1, Claudia Mannini2, Elisa Chellini2, Giovanni A Fontana2.   

Abstract

Chronic obstructive pulmonary disease (COPD) is common in older people. Inhaled medications are the mainstay of pharmacological treatment of COPD, and are typically administered by handheld inhalers, such as pressurised metered-dose inhalers and dry powder inhalers, or by nebulisers. For each of the three major categories of aerosol delivery devices, several new inhalers have recently been launched, each with their own particularities, advantages and disadvantages. Consequently, broader availability of new drug-device combinations will increase prescription opportunities. Despite this, however, there is limited guidance available in published guidelines on the choice of inhalers, and still less consideration is given to elderly patients with COPD. The aim of this article is to provide a guide for healthcare professionals on device selection and factors to be considered for effective inhaled drug delivery in elderly COPD patients, including device factors (device type and complexity of use), patient factors (inspiratory capabilities, manual dexterity and hand strength, cognitive ability, co-morbidities) and considerations for healthcare professionals (proper education of patients in device use).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27216613     DOI: 10.1007/s40266-016-0377-y

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  97 in total

1.  Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation.

Authors:  J C Waldrep; R Dhand
Journal:  Curr Drug Deliv       Date:  2008-04       Impact factor: 2.565

Review 2.  Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology.

Authors:  D Acerbi; G Brambilla; I Kottakis
Journal:  Pulm Pharmacol Ther       Date:  2006-05-27       Impact factor: 3.410

Review 3.  Problems with inhaler use: a call for improved clinician and patient education.

Authors:  James B Fink; Bruce K Rubin
Journal:  Respir Care       Date:  2005-10       Impact factor: 2.258

Review 4.  Cognitive function in COPD.

Authors:  J W Dodd; S V Getov; P W Jones
Journal:  Eur Respir J       Date:  2010-04       Impact factor: 16.671

5.  Characteristics predicting incorrect metered-dose inhaler technique in older subjects.

Authors:  S L Gray; D M Williams; C C Pulliam; M A Sirgo; A L Bishop; J F Donohue
Journal:  Arch Intern Med       Date:  1996-05-13

6.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

7.  Effectiveness and acceptability of a domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer.

Authors:  G Balzano; R Battiloro; M Biraghi; F Stefanelli; S Fuschillo; C Gaudiosi; E De Angelis
Journal:  J Aerosol Med       Date:  2000

8.  A comparison of breath-actuated and conventional metered-dose inhaler inhalation techniques in elderly subjects.

Authors:  K R Chapman; L Love; H Brubaker
Journal:  Chest       Date:  1993-11       Impact factor: 9.410

9.  Identification of a predominant COPD phenotype in clinical practice.

Authors:  Massimo Pistolesi; Gianna Camiciottoli; Matteo Paoletti; Cecilia Marmai; Federico Lavorini; Eleonora Meoni; Carlo Marchesi; Carlo Giuntini
Journal:  Respir Med       Date:  2008-01-08       Impact factor: 3.415

10.  Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians.

Authors:  David Price; Brooke Harrow; Mark Small; James Pike; Victoria Higgins
Journal:  World Allergy Organ J       Date:  2015-09-10       Impact factor: 4.084

View more
  18 in total

Review 1.  Lipid-based pulmonary delivery system: a review and future considerations of formulation strategies and limitations.

Authors:  Cheng Loong Ngan; Azren Aida Asmawi
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

Review 2.  Routine Use of Budesonide/Formoterol Fixed Dose Combination in Elderly Asthmatic Patients: Practical Considerations.

Authors:  Nicola Scichilone; Fulvio Braido; Federico Lavorini; Mark L Levy; Omar S Usmani
Journal:  Drugs Aging       Date:  2017-05       Impact factor: 3.923

Review 3.  Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes.

Authors:  Omar Sharif Usmani; Federico Lavorini; Jonathan Marshall; William Christopher Nigel Dunlop; Louise Heron; Emily Farrington; Richard Dekhuijzen
Journal:  Respir Res       Date:  2018-01-16

Review 4.  Role of nebulized glycopyrrolate in the treatment of chronic obstructive pulmonary disease.

Authors:  Pierachille Santus; Dejan Radovanovic; Andrea Cristiano; Vincenzo Valenti; Maurizio Rizzi
Journal:  Drug Des Devel Ther       Date:  2017-11-15       Impact factor: 4.162

5.  Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation.

Authors:  David B Price; Sen Yang; Simon Wan Yau Ming; Antony Hardjojo; Claudia Cabrera; Andriana I Papaioannou; Stelios Loukides; Vicky Kritikos; Sinthia Z Bosnic-Anticevich; Victoria Carter; Paul M Dorinsky
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-12-13

Review 6.  Spacer devices for inhaled therapy: why use them, and how?

Authors:  Walter Vincken; Mark L Levy; Jane Scullion; Omar S Usmani; P N Richard Dekhuijzen; Chris J Corrigan
Journal:  ERJ Open Res       Date:  2018-06-18

Review 7.  Continued Innovation in Respiratory Care: The Importance of Inhaler Devices.

Authors:  Sinthia Zrinka Bosnic-Anticevich
Journal:  Tuberc Respir Dis (Seoul)       Date:  2018-04

8.  Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine care.

Authors:  Bo Ding; Mark Small; Gina Scheffel; Ulf Holmgren
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-03-16

9.  Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial.

Authors:  Pablo Altman; Luis Wehbe; Juergen Dederichs; Tadhg Guerin; Brian Ament; Miguel Cardenas Moronta; Andrea Valeria Pino; Pankaj Goyal
Journal:  BMC Pulm Med       Date:  2018-06-14       Impact factor: 3.317

10.  A comparative analysis of errors in inhaler technique among COPD versus asthma patients.

Authors:  Birsen Ocakli; Ipek Ozmen; Eylem Acartürk Tunçay; Sinem Gungor; Hilal Altinoz; Nalan Adiguzel; Zafer Ali Sak; Gokay Gungor; Zuhal Karakurt; Peri Arbak
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.